NutraConnect KEY INGREDIENTS References et al. (2006)) Body mass index, metabolic syndrome, and risk of type 1// Xiang AH, Peters RK, Kjos SL, 2 diabetes or cardiovascular disease. Goico J, Ochoa C, Marroquin A, et J. Clin Endocrinol Metab 91 2906- al. (2004) Pharmacological treatment 2912. of insulin resistance at two different stages in the evolution of type 2 7// Wannamethee SG, Shaper AG, diabetes: impact on glucose tolerance Walker M. (2005) Overweight and and beta-cell function. J Clin Endocri- obesity and weight change in middle nol Metab; 89 :2846–51. aged men: impact on cardiovascular disease and diabetes. J Epidemiol 2// Stumvoll M, Goldstein BJ, van Community Health 59: 134-139, Haeften TW. (2005) Type 2 diabetes: 2005. principles of pathogenesis and the- rapy. Lancet; 365:1333–46. 8// J. Tuomilehto, J. Lindstrom, J.G. Eriksson, T.T. Valle, H. Hamalainen, 3// Gloyn AL, McCarthy MI. (2008) P. Ilanne-Parikka, et al., (2001) Genetics: how the UKPDS contributed Prevention of type 2 diabetes mellitus to determining the genetic landscape by changes in lifestyle among subjects of type 2 diabetes. Diabet Med;25 with impaired glucose tolerance, N. (Suppl 2):35–40. Engl. J. Med. 344 (18):1343–1350. 4// Hu FB, Manson JE, Stampfer MJ, 9// W.C. Knowler, E. Barrett-Connor, et al. (2001) Diet, lifestyle, and the S.E. Fowler, R.F. Hamman, J.M. risk of type 2 diabetes mellitus in wo- Lachin, E.A. Walker, et al. (2002) men. N Engl J Med 345; 790-797. Reduction in the incidence of type 2 diabetes with lifestyle intervention or 5// Vereecken CA, Todd J, Roberts C, metformin, N. Engl. J. Med.; 346 (6) Mulvihill C, Maes L. (2006) Television :393–403. viewing behaviour and associations with food habits in different countries. 10// Wasswa J, Tang J, Gu X. Public Health Nutr 9; 244-250, (2007) Utilization of fish processing 2006. by-products in the gelatin industry. Food Reviews International; 23 6// Meigs JB, Wilson PW, Fox CS, :159−174.